Cyclo Therapeutics Inc.

0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM
0.72
0.00%
After-hours: Mar 25, 2025, 04:00 PM EDT

Cyclo Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00
Net Income -20.06M -15.45M -14.29M -8.94M -7.53M -4.26M -3.83M -4.22M -2.55M -592.69K 204.91K 74.2K -97.77K -37.53K -193.13K -413.23K 653.55K -101.83K -172.46K -561.49K 294.98K 165.58K -113.88K -510.83K
Depreciation & Amortization 19.28K 19.48K 16.83K 12.76K 5.68K 10.12K 9.27K 107.1K 169.03K 152.45K 148.04K 142.64K 32.75K 20.94K 20.58K 22.87K 24.37K 27.46K 35.01K 27.76K 37.81K 24.19K 51.29K 26.41K
Stock-Based Compensation 736.91K 513.57K 470.88K 271.31K 436.7K 83.42K 118.68K 121.46K 74.6K 160.2K 40K 22K 116.18K 162.99K 265.81K 208.75K n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -62.29K -248.56K -297 412.00 2.16K 844.28K -6.97K -39.03K -1.57K -3.22K 889.00 -10.13K 4.31K -5.13K 536.88K 444.31K 16.84K -22.75K 26.87K 53.05K -82.64K -146.47K -41.27K 148.91K
Other Non-Cash Items 52.92K -148.25K 21.93K 74.7K 13.27K 64.02K 53.48K 3.31K 141.3K 88.28K 93.46K 16.86K -97.77K 15.89K -20.83K 92.17K 149.99K 148.38K 182.3K 657.9K 54.85K 37.01K 56.08K 82.87K
Deferred Income Tax n/a n/a n/a -74.7K n/a -51.87K -50.79K 913.67K 120K -88.28K 80K 25K 91.77K 25K 76.00 200K -450K n/a 225K n/a -225K n/a n/a 195K
Change in Working Capital 3.06M -48.15K -1.23M 117.35K 487.4K 960.9K 639.94K 127.37K 57.03K -351.12K -9.87K -200.21K 140.62K 22.57K 35.63K -45.81K -11.03K -47.91K 23.29K 81.23K -97.68K -178.65K -16.92K 177.85K
Operating Cash Flow -16.19M -15.11M -15.01M -8.54M -6.59M -3.19M -3.06M -2.95M -1.99M -631.16K 556.54K 58.5K 185.78K 209.86K 108.13K 64.74K 370.22K 26.11K 128.77K 205.4K 64.96K 48.13K -23.43K -28.7K
Capital Expenditures -2.42K -15.09K -22.5K -53.13K -1.32K -2.96K -6.86K -9.34K -419.24K -173.88K -156.92K -166.17K -553.78K -449.18K -43.41K -84.42K -84.3K -27.63K -22.58K -80.88K -54.72K -17.88K -9.29K -97.01K
Acquisitions n/a n/a n/a n/a n/a n/a 4.65K 924.7K 700.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.54K n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -263.99K -110.54K -116.05K n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 264.84K 134.69K 131.38K n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a 53.26K 37.32K 39.08K 37.46K 35.9K 39.06K 952.28K 700.00 n/a 2K n/a n/a -6.5K 6.71K -17.07K n/a n/a -3.87K -3.05K -11.17K 748.00 9.69K 18.35K
Investing Cash Flow -2.42K 38.17K 14.82K -14.05K 36.13K 32.94K 32.2K 942.93K -418.54K -173.88K -154.92K -166.17K -553.78K -449.18K -36.7K 163.35K -213.6K -6.79K -137.95K -83.93K -65.89K -17.13K 392.00 -78.66K
Debt Repayment n/a 6.78K -6.78K 158.52K n/a n/a n/a -754.03K -40.46K -57.28K -134.28K -46.57K 397.83K -1.02K n/a -161.4K 13.22K -26.72K -54.16K -38.36K -37.56K -14.82K 14.54K 20.63K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -9.23K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 14.15M n/a n/a n/a 130.06K n/a n/a n/a n/a -50K -21.66K n/a -9.5K 469.00 n/a n/a 16.51K n/a n/a n/a n/a 21.88K n/a n/a
Financial Cash Flow 23.89M 6.78K 18.76M 18.62M 7.12M 4.1M 3.34M 1.13M 1.87M 2.92M -155.94K 3.43K 388.33K 7.2K -9.23K -161.4K 29.73K -26.72K -54.16K -34.86K -37.56K 7.05K 14.54K 50.63K
Net Cash Flow 7.7M -15.07M 3.77M 10.06M 566.31K 946.44K 310.78K -882.04K -537.82K 2.11M 245.68K -104.24K 20.32K -232.12K 62.2K 66.69K 186.35K -7.4K -63.34K 86.61K -38.49K 38.05K -8.5K -56.73K
Free Cash Flow -16.19M -15.13M -15.03M -8.59M -6.59M -3.19M -3.07M -2.96M -2.41M -805.04K 399.62K -107.67K -368K -239.31K 64.72K -19.68K 285.92K -1.51K 106.19K 124.52K 10.25K 30.25K -32.72K -125.71K